AUTL

AUTOLUS THERAPEUTICS LTD

AUTL·05280R100·US·ADR·Healthcare - Biotechnology-13D/G

AUTL (AUTOLUS THERAPEUTICS LTD) is held by 44 institutional investors as of Q1 2026. Largest holders: Blackstone Inc. ($28.3M), SCHRODER INVESTMENT MANAGEMENT GROUP ($12.1M), BNP Paribas Asset Management Holding S.A. ($4.6M). Net institutional sentiment: Mixed.

44
Holders
Avg rating(10 Elite)
$65.7M
Total Value
45% (47)
Fund Consensus
17 buying - 21 selling
AUTLSmart Money Verdict
View all
Held by 44 funds
10 elite
Who's Trading
ActivistMAMAK Capital Fund LP12.6%May 15, 2026
ActivistARArmistice Capital, LLC5.9%May 15, 2026
ActivistDTDeep Track Capital, LP1.0%Nov 14, 2025
ActivistWellington Management Group LLPWellington Management Group LLP0.0%Oct 6, 2025
ActivistFMR LLCFMR LLC3.8%May 12, 2025
ActivistSPSyncona Portfolio Limited10.8%May 7, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
20.5M$28.3M0.1%-66.98%
0
Unchanged
9.5M$12.1M0.0%-60.02%
0
Unchanged
3.4M$4.6M0.0%-18.27%
0
Decreased
2.3M(-25.9%)$3.2M0.0%-9.77%
0
Decreased
1.8M(-5.9%)$2.5M0.0%-16.77%
0
Decreased
1.5M(-59.8%)$2M0.0%-26.69%
0
Increased
1.3M(+48.9%)$1.8M0.0%-18.37%
35
Increased
1.1M(+2.7%)$1.6M0.0%-31.48%
26
New
971,691$1.3M0.0%-0.62%
35
Decreased
941,823(-32.6%)$1.3M0.0%-24.68%
0
Decreased
935,403(-4.5%)$1.2M0.0%-22.20%
0
Unchanged
698,262$963,6020.0%-15.26%
0
New
542,857$749,1430.0%-0.62%
34
Decreased
459,404(-60.4%)$633,9780.0%-11.95%
0
Increased
426,983(+39.8%)$589,2370.0%-13.92%
32
Decreased
399,143(-33.4%)$550,8170.0%-27.18%
0
Decreased
245,785(-63.9%)$339,1840.0%+1.26%
0
Increased
207,856(+5.5%)$286,8420.0%-30.63%
25
New
204,728$282,5250.0%-0.62%
32
Unchanged
195,000$247,6500.0%-60.82%
0

Showing 1-20 of 47

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used